We are live on ! Find out more
JUSA

JPMorgan U.S. Research Enhanced Large Cap ETF

2 hedge funds and large institutions have $10.5M invested in JPMorgan U.S. Research Enhanced Large Cap ETF in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

90.06% more ownership

Funds ownership: 0%90.06% (+90%)

Holders
2
Holders Change
+2
Holders Change %
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$10.3M
2
TRCT
Tower Research Capital (TRC)
New York
+$366K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$10.1M +$10.3M +200,000 New
TRCT
2
Tower Research Capital (TRC)
New York
$362K +$366K +7,137 New

JUSA Hedge Fund Activity: Q1 2025 in Review

2 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) for Q1 2025, worth a combined $10.5M.

Buyers outnumbered sellers: 2 funds opened new JUSA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $10.3M.

  • 2 institutional investors held JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $10.5M of JPMorgan U.S. Research Enhanced Large Cap ETF stock for Q1 2025.
  • 2 funds opened new JPMorgan U.S. Research Enhanced Large Cap ETF positions in Q1 2025 and 0 closed out, a net change of +2 holders.
  • The largest JPMorgan U.S. Research Enhanced Large Cap ETF buyer in Q1 2025 was JP Morgan Chase, an estimated $10.3M added.

Based on aggregated 13F filings for Q1 2025.